Based on the critical role of SOX2 in cancer stem cell maintenance and cancer progression, it has become an effective therapeutic target, and SOX2 peptide immunization has been shown to delay tumor onset and activate cytotoxic T lymphocytes in mouse models 67. The gene discussed is SOX2; the disease is cancer.